Shares of Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) have been assigned an average rating of “Moderate Buy” ...

If you’re in the market for an intriguing biotech pick and can manage high risk, take a look at Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)stock. Actinium Pharmaceuticals develops targeted ...

Actinium Pharmaceuticals (NYSE:ATNM) traded higher on Tuesday as H.C. Wainwright highlighted its buyout potential after its ...

Actinium Pharmaceuticals, Inc. (NYSE:ATNM – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the stock ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Shares in Actinium Pharmaceuticals have lost almost two-thirds of their value after the FDA asked for a second clinical trial before it would consider reviewing the company's Iomab-B radioligand ...

Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ...

In a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Actinium Pharmaceuticals (ATNM – Research Report), ...

Short interest in Actinium Pharmaceuticals Inc (AMEX:ATNM) increased during the last reporting period, rising from 2.04M to 2.08M. This put 6.67% of the company's publicly available shares short.

Reveal insider sentiment with alternative data that tracks buy and sell trades made by top managers and company directors.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or ...